| This week's sponsor is Premier Research. | |  | Placebo Response: Mitigating the Threat to Pain Trials
Fibromyalgia Awareness Day, May 12, is a timely reminder of how placebo response can skew analgesia clinical trials. Our placebo problem eBook can help you take the pain out of pain trials. Premier Research. It's what we do. Best. |
Today's Rundown Featured Story | | | Thursday, May 10, 2018 Eli Lilly is acquiring Armo Biosciences and its lead asset, pegilodecakin, for $1.6 billion. The drug has shown promise both as a single agent and in combination treatments for multiple tumor types. |
|
|
| This week's sponsor is Deloitte. | |  | |
Top Stories Wednesday, May 9, 2018 Provention Bio has filed to raise up to $50 million in its Nasdaq IPO, which will bankroll several clinical programs, including a pair of inflammatory bowel disease assets it picked up from Janssen last fall. Thursday, May 10, 2018 Rhythm Pharma has additional data for its first-in-class obesity therapy setmelanotide—published in the prestigious journal Nature Medicine—showing that the drug’s effects can extend for over a year. Monday, May 7, 2018 Avoid delays in gene transfer trial start-up with tips from leading IRB and IBC experts. Thursday, May 10, 2018 Astellas is paying Aquinox Pharmaceuticals $25 million upfront for regional rights to rosiptor. The deal gives Astellas the right to develop the phase 3 SHIP1 activator in Japan and certain other nations in Asia. Thursday, May 10, 2018 Pluristem Therapeutics is planning to publish data from a phase 2 trial of its placenta-derived cell therapy PLX-PAD next month. The data set on patients with intermittent claudication will become the biggest generated by Pluristem to date when it is finalized in the coming weeks. Thursday, May 10, 2018 Novartis didn't assign blame for the "suspicious" payments it made to President Trump's personal attorney, Michael Cohen. It only said its new CEO, Vas Narasimhan, wasn't involved. But company insiders now point the finger at former CEO Joe Jimenez—and they say Novartis didn't buy policy advice. It paid for access. | This week's sponsor is LabConnect. | |  | SciOps Provides Solutions for Lost Samples, Missed Timelines and Scientific Personnel Needs
Managing outsourced studies can be challenging. Read how our team’s functional and strategic resourcing services allow you to focus on other core competencies. |
Resources Sponsored by: Seton Hall Law 4-day interactive educational program trusted by multi-national companies as part of their compliance training for employees. Explore legal, regulatory and ethical issues faced by pharmaceutical, biotech and medical device manufacturers operating globally. Visit event homepage for session topics. Sponsored by: USDM Life Sciences What are the biggest trends in life sciences this year? Presented by: Patheon There are many parenteral dosage forms from which the pharmaceutical scientist can choose to develop their drug product. In this article, the author discusses the choices available and strategies which can be employed at the different stages of development. Sponsored by: Veeva Systems Explore a new model for events management, and learn how to deliver more value. Sponsored by: Veeva Systems To deliver value to key opinion leaders, medical affairs needs to tailor their engagement with deeper analytics and insights. Sponsored by: Veeva Systems Learn how leading companies, from the world’s top pharma to emerging biotechs, are empowering their medical affairs teams. Sponsored by: Veeva Systems Learn how to reduce change management burden, keep systems current, and maintain compliance by applying a risk-based approach to change management of GxP systems. Sponsored by: Veeva Systems UCB took a more holistic approach to managing regulatory processes. Read how their efforts are paying off. Sponsored by: Veeva Systems Find out how to eliminate regulatory’s tracking spreadsheets for good. Sponsored by: Veeva Systems Learn how cloud-enabled solutions provide real-time insights and actionable analytics to improve clinical trial safety and performance in this short presentation. Sponsored by: Docusign Life science companies are experiencing a significant transformation in how they bring new products to market. Drug Approval, Manufacturing Quality & Regulation 2018 | Online Translational Biomarkers: Advancing Neuroscience Drug Discovery and Development May 14, 2018 | South San Francisco, CA
MIXiii-Biomed 2018 May 15-17, 2018 | Tel-Aviv, Israel Drug Development Immersion May 17-18, 2018 | Boston, MA BIO International Convention June 4-7, 2018 | Boston, MA
FierceBiotech Executive Breakfast at BIO 2018 – CAR-T 2.0: Innovation Never Stands Still June 6, 2018 | Boston, MA BioBasics: Biotech for the Non-Scientist June 13-14, 2018 | Toronto, Canada BioBasics: Biotech for the Non-Scientist June 13-14, 2018 | West Windsor, NJ Sensors Expo & Conference Conference & Expo: June 26-28, 2018 | Pre-Conference Symposia: June 25, 2018 | San Jose, CA 18th International Biotechnology Symposium and Exhibition August 12-17, 2018 | Montreal, Canada FierceBiotech 3rd Drug Development Forum October 1–3, 2018 | Hilton Boston Logan Airport Hotel | Boston, MA Drug Development Boot Camp® 2018 November 14-15, 2018 | Boston, MA | Register and start preparing Today! | 
